Decrease of caffeine elimination in man during co-administration of 4-quinolones
- PMID: 3480885
- DOI: 10.1093/jac/20.5.729
Decrease of caffeine elimination in man during co-administration of 4-quinolones
Abstract
The single dose pharmacokinetics of caffeine (220-230 mg per dose) were investigated in 12 healthy male volunteers before and during treatment with ofloxacin (200 mg bd), ciprofloxacin (250 mg bd) and enoxacin (400 mg bd) with a cross-over study design. None of the parameters: mean elimination half-life (T1/2el), Cmax, total body clearance (Cltot) and the volume of distribution (aVd) of caffeine were noticeably altered by administration of ofloxacin. Striking changes were observed, however, after administration of enoxacin: the T1/2el was prolonged by as much as 260%, the Cmax increased by 41%; the aVd was reduced by 20% and Cltot by 78% (mean values). Treatment with ciprofloxacin led to a prolongation of T1/2el by 15%, to a decrease of aVd by 25% and to a 33% decrease of Cltot. The results of this intra-individual comparison of caffeine pharmacokinetic data demonstrate that treatment with ciprofloxacin and enoxacin may have a significant inhibitory effect on caffeine elimination.
Similar articles
-
Interaction between quinolones and caffeine.Drugs. 1987;34 Suppl 1:170-4. doi: 10.2165/00003495-198700341-00035. Drugs. 1987. PMID: 3481318 Clinical Trial.
-
Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.Rev Infect Dis. 1988 Jan-Feb;10 Suppl 1:S83-9. Rev Infect Dis. 1988. PMID: 3162327
-
Gyrase-inhibitors impair caffeine elimination in man.Methods Find Exp Clin Pharmacol. 1987 Mar;9(3):193-8. Methods Find Exp Clin Pharmacol. 1987. PMID: 3037212 No abstract available.
-
Quinolones.Prog Drug Res. 1987;31:243-56. doi: 10.1007/978-3-0348-9289-6_7. Prog Drug Res. 1987. PMID: 3326031 Review. No abstract available.
-
A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora.Infection. 1988;16(1):8-12. doi: 10.1007/BF01646921. Infection. 1988. PMID: 3283041 Review.
Cited by
-
Clinically significant pharmacokinetic interactions between dietary caffeine and medications.Clin Pharmacokinet. 2000 Aug;39(2):127-53. doi: 10.2165/00003088-200039020-00004. Clin Pharmacokinet. 2000. PMID: 10976659 Review.
-
Multiple-dose pharmacokinetics of concurrent oral ciprofloxacin and rifampin therapy in elderly patients.Antimicrob Agents Chemother. 1990 Mar;34(3):442-7. doi: 10.1128/AAC.34.3.442. Antimicrob Agents Chemother. 1990. PMID: 2185691 Free PMC article. Clinical Trial.
-
The effect of enzyme inhibition on the metabolism and activation of tacrine by human liver microsomes.Br J Clin Pharmacol. 1994 Jul;38(1):15-22. doi: 10.1111/j.1365-2125.1994.tb04316.x. Br J Clin Pharmacol. 1994. PMID: 7946932 Free PMC article.
-
4-quinolones inhibit biotransformation of caffeine.Eur J Clin Pharmacol. 1988;35(6):651-6. doi: 10.1007/BF00637602. Eur J Clin Pharmacol. 1988. PMID: 2853056 Clinical Trial.
-
Pharmacokinetic disposition of quinolones in human body fluids and tissues.Clin Pharmacokinet. 1989;16 Suppl 1:5-24. doi: 10.2165/00003088-198900161-00004. Clin Pharmacokinet. 1989. PMID: 2653696 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical